Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study.
Authors: Flejou, J.-F., Andre, T., Chibaudel, B., Scriva, A., Hickish, T., Tabernero, J., Van Laethem, J.-L., Banzi, M., Maartense, E., Shani, A., Carlsson, G., Scheithauer, W., Papamichael, D., Moehler, M., Landolfi, S., Demetter, P., Duval, A., Lee, M., Colote, S., De Gramont, A.
Journal: JOURNAL OF CLINICAL ONCOLOGY
Publication Date: 20/05/2013
Volume: 31
Issue: 15
eISSN: 1527-7755
ISSN: 0732-183X
Source: Web of Science
Preferred by: Tamas Hickish